A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

An In Vitro Method to Determine the Anti-Apoptotic Activity of Antibodies against TNFα

687 views

July 8th, 2025

In This Article

Abstract

Source: Tierrablanca-Sánchez, L., et al. Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method. J. Vis. Exp. (2017)

This video demonstrates a technique for assessing the efficacy of antibodies against tumor necrosis factor-alpha (TNFα), an inflammatory cytokine, through an in vitro bioanalytical approach. TNFα, when introduced to stressed cells, triggers apoptosis. However, binding to the antibodies confines TNFα, averting apoptosis. The degree of apoptosis is quantified using a bioluminescence assay.

Protocol

1. Preparation of the Media and Solutions

  1. Prepare the culture medium: RPMI-1640 with 10% fetal bovine serum (FBS), pH 7.4.
  2. Prepare assay culture medium: RPMI-1640 without phenol red but with 1% FBS, pH 7.4.
  3. Prepare cell wash solution: Dulbecco's phosphate-buffered saline (DPBS) Mg- and Ca-free solution with 0.02% EDTA, pH 7.4.
  4. Prepare cell detachment solution: 0.125% trypsin with 1 mM ethylenediaminetetraacetic acid (EDTA).
    1. Thaw 100 mL of a 0.25% solution of trypsin-EDTA and transfer to a sterile 500-mL flask.
    2. Mix with 100 mL of cell wash solution and dispense 15 mL aliquots into 15 mL s....

Access restricted. Please log in or start a trial to view this content.

Results

Microplate layout for TNF-α assay; reference, sample, control; dilution series chart.
Figure 1: Disposition of samples in the assay plates. B1 to G11 are well coordinates in the microplates and describe the positions where the sample dilutions are placed. Missing coordinates are wells filled with controls and assay culture medium (A1-A12 and H1-H1.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
WEHI 164ATCCCRL-1751Fibrosarcoma cells from Mus musculus
RPMI-1640 MediumATCC30-2001Store medium at 2 °C to 8 °C
RPMI 1640 Medium, no phenol redGIBCO11835-030Store medium at 2 °C to 8 °C
Trypsin-EDTA(0.25%),phenol redGIBCO25200-056Store medium at -10 °C to -20 °C
DPBS, no calcium, no magnesiumGIBCO14190-136Store medium at 2 °C to 8 °C
Recombinant Human TNF-alpha ProteinR&D Systems210-TA-020Store at -20 °C to -70 °C
Fetal Bovine Serum (U.S), Super Low IgGHyCloneSH3089803Store at -10 °C to -20 °C
Fetal Bovine Serum (U.S.), CharacterizedHyCloneSH3007103Store at -10 °C to -20 °C
Caspase-Glo 3/7 Assay kitPromegaG8093Store the Caspase-Glo. 3/7 Substrate and Caspase-Glo. 3/7 Buffer at –20 ºC protected fromLight
EDTA, Disodium Salt, Dihydrate, Crystal, A.C.S. ReagentJ.T.Baker8993-01--
Sample mAb AdalimumabProbiomedNAFinal concentrations in the microplate are: 0.666, 0.333, 0.167, 0.111, 0.083, 0.056, 0.042, 0.028, 0.014 and 0.004 μg/mL
Reference and Control mAb AdalimumabAbbvieNAFinal concentrations in the microplate are: 0.666, 0.333, 0.167, 0.111, 0.083, 0.056, 0.042, 0.028, 0.014 and 0.004 μg/mL
Microplate ReaderMolecular Devices89429-536SpectraMax M3 Multi-Mode
Microplate reader SoftwareMolecular Devices--SoftMax Pro 6.3 GxP
IncubatorRevco30482Revco RNW3000TABB Forced-Air CO2
Laminar Flow HoodThe Baker Company200256Baker SG603A-HE | High Efficiency, Class II Type A2

Tags

TNF Alpha NeutralizationAntibody Potency AssayIn Vitro Bioanalytical MethodBioluminescence AssayCaspase Activation InhibitionSerum Deprived FibroblastsApoptosis Detection MethodLuminescence Intensity MeasurementAntibody Dilution ProtocolPlate Reader Spectrophotometry